Stock comparison
Incyte
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
INCY
Incyte
Market cap
$19.46B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | INCY | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 63C | 69B | MTD |
| Benjamin Graham | 73B | 65B | INCY |
| Philip Fisher | 61C | 63C | MTD |
| Peter Lynch | 50C | 66B | MTD |
| Joel Greenblatt | 45D | 68B | MTD |
| Charlie Munger | 60C | 74B | MTD |
| Terry Smith | 66B | 70B | MTD |
Side-by-side metrics
| Metric | INCY | MTD |
|---|---|---|
| Market cap | $19.46B | $22.29B |
| P/E (TTM) | 14.0x | 25.3x |
| EV/EBIT | 12.4x | 21.6x |
| ROIC (TTM) | 19.98% | 36.09% |
| Gross margin | 91.86% | 57.79% |
| Net margin | 26.71% | 21.4% |
| Revenue CAGR 5y | 14.55% | 2.01% |
| EPS CAGR 5y | 11.26% | 6.12% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
INCY leads on
- Revenue CAGR 5y14.55%vs 2.01%+86%
- EPS CAGR 5y11.26%vs 6.12%+46%
- P/E (TTM)14.0xvs 25.3x+45%
- EV/EBIT12.4xvs 21.6x+43%
MTD leads on
- Debt / Equity-vs 0.0x+100%
- ROIC (TTM)36.09%vs 19.98%+45%
- Market cap$22.29Bvs $19.46B+13%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.